{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:43:07Z","timestamp":1791085387734,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004762","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000}}],"reference-count":110,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004762.pub2","type":"journal-article","created":{"date-parts":[[2006,1,20]],"date-time":"2006-01-20T04:08:27Z","timestamp":1137730107000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Drug treatment for myotonia"],"prefix":"10.1002","volume":"2011","author":[{"given":"Jeroen","family":"Trip","sequence":"first","affiliation":[{"name":"Diaconessenhuis Meppel; Neurologist; Hoogeveenseweg 38 Meppel Netherlands 7943 KA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gea G","family":"Drost","sequence":"additional","affiliation":[{"name":"Radboud University Nijmegen Medical Center; Department of Neurophysiology; PO Box 9101 Nijmegen Netherlands 6500 HB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel GM","family":"van Engelen","sequence":"additional","affiliation":[{"name":"Radboud University Nijmegen Medical Center; Neuromuscular Center Nijmegen; PO Box 9101 Nijmegen Netherlands 6500 HB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C G","family":"Faber","sequence":"additional","affiliation":[{"name":"MUML; Department Neurology; PO Box 5000 Maastricht Netherlands 6202 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD004762.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.40.9.1473","article-title":"Effect of clomipramine on myotonia: a placebo-controlled, double-blind, crossover trial","volume":"40","author":"Antonini","year":"1990","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD004762.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1212\/WNL.33.5.599-a","article-title":"The treatment of myotonia: evaluation of chronic oral taurine therapy","volume":"33","author":"Durelli","year":"1983","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD004762.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/jnnp.45.5.461","article-title":"A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy","volume":"45","author":"Finlay","year":"1982","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004762.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002060-198910000-00003","article-title":"A pilot controlled study of the use of imipramine to reduce myotonia","volume":"68","author":"Gascon","year":"1989","journal-title":"American Journal of Physical Medicine & Rehabilitation"},{"issue":"2","key":"10.1002\/14651858.CD004762.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/jnnp.50.2.199","article-title":"Nifedipine in the treatment of myotonia in myotonic dystrophy","volume":"50","author":"Grant","year":"1987","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD004762.pub2-BIB0006|cit6","first-page":"199","article-title":"Treatment of myotonia with mexiletine","volume":"9","author":"Kratz","year":"1986","journal-title":"Muscle & Nerve (Abstract)"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0404.1992.tb05103.x","article-title":"Treatment of myotonia with antiarrhythmic drugs","volume":"86","author":"Kwiecinski","year":"1992","journal-title":"Acta Neurologica Scandinavica"},{"issue":"8","key":"10.1002\/14651858.CD004762.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1212\/WNL.16.8.831","article-title":"Trial of diazepam in myotonia - A controlled clinical trial","volume":"16","author":"Lewis","year":"1966","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/brain\/82.1.81","article-title":"The treatment of myotonia: A controlled clinical trial","volume":"82","author":"Leyburn","year":"1960","journal-title":"Brain"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.17.4.359","article-title":"Therapy of myotonia. A double-blind evaluation of diphenylhydantoin, procainamide, and placebo","volume":"17","author":"Munsat","year":"1967","journal-title":"Neurology"},{"issue":"13","key":"10.1002\/14651858.CD004762.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1212\/01.wnl.0000257825.29703.e8","article-title":"Efficacy of propafenone in paramyotonia congenita","volume":"68","author":"Alfonsi","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD004762.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2796.1990.tb00282.x","article-title":"Effect of sodium selenite and vitamin E treatment in myotonic dystrophy","volume":"228","author":"Backman","year":"1990","journal-title":"Journal of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004762.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1017\/S0317167100026305","article-title":"Treatment of paramyotonia congenita with acetazolamide","volume":"14","author":"Benstead","year":"1987","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"2","key":"10.1002\/14651858.CD004762.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00316381","article-title":"Clinical and electrophysiological observations in patients with myotonic muscle disease and the therapeutic effect of N-propyl-ajmalin","volume":"210","author":"Birnberger","year":"1975","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD004762.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/jnnp.46.6.587","article-title":"The depression of myotonic dystrophy: response to imipramine","volume":"46","author":"Brumback","year":"1983","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004762.pub2-BIB0016|cit16","first-page":"193","article-title":"Beneficial response to a calcium channel antagonist in myotonic syndromes","volume":"34","author":"Cook","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004762.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.410110305","article-title":"Taurine and hyperexcitable human muscle: effects of taurine on potassium-induced hyperexcitability of dystrophic myotonic and normal muscles","volume":"11","author":"Durelli","year":"1982","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004762.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jnnp.17.1.83","article-title":"The treatment of dystrophia myotonica with A.C.T.H","volume":"17","author":"Garai","year":"1954","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004762.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/brain\/78.1.81","article-title":"Procaine amide in the treatment of myotonia","volume":"78","author":"Geschwind","year":"1955","journal-title":"Brain"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0020|cit20","first-page":"133","article-title":"Effect of acetazolamide on myotonia","volume":"102","author":"Griggs","year":"1977","journal-title":"Transactions of the American Neurological Association"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ana.410030614","article-title":"Effects of acetazolamide on myotonia","volume":"3(6)","author":"Griggs","year":"1978","journal-title":"Annals of Neurology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD004762.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.39.2.219","article-title":"Randomized controlled trial of testosterone in myotonic dystrophy","volume":"39","author":"Griggs","year":"1989","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004762.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0404.1978.tb05870.x","article-title":"Baclofen trial in six myotonic dystrophy patients","volume":"57","author":"Guilleminault","year":"1978","journal-title":"Acta Neurologica Scandinavica"},{"issue":"8732","key":"10.1002\/14651858.CD004762.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0140-6736(91)93342-7","article-title":"Response to treatment with antihistamines in a family with myotonia congenita","volume":"337","author":"Hughes","year":"1991","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD004762.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/mus.880170710","article-title":"Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy","volume":"17","author":"Jackson","year":"1994","journal-title":"Muscle and Nerve"},{"issue":"7869","key":"10.1002\/14651858.CD004762.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(74)90036-1","article-title":"Effect of baclofen on myotonia","volume":"1","author":"Karli","year":"1974","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD004762.pub2-BIB0027|cit27","first-page":"661","article-title":"A clinical trial of creatine monohydrate in muscular dystrophy patients","volume":"44","author":"Matsumura","year":"2004","journal-title":"Clinical Neurology"},{"issue":"5","key":"10.1002\/14651858.CD004762.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00313863","article-title":"Antimyotonic therapy with tocainide under ECG control in the myotonic dystrophy of Curschmann-Steinert","volume":"232","author":"Mielke","year":"1985","journal-title":"Journal of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD004762.pub2-BIB0029|cit29","first-page":"983","article-title":"Myotonic dystrophy: quantification of muscle weakness and myotonia and the effect of amitriptyline and exercise","volume":"71","author":"Milner-Brown","year":"1990","journal-title":"Archives of physical medicine and rehabilitation"},{"issue":"8","key":"10.1002\/14651858.CD004762.pub2-BIB0030|cit30","first-page":"464","article-title":"Clinical and neurophysiological findings in serum controlled diphenylhydantoin application - considerations on myotonic dystrophy therapy","volume":"32","author":"M\u00fcller","year":"1980","journal-title":"Psychiatrie, Neurologie, und medizinische Psychologie"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.0954-6820.1986.tb03331.x","article-title":"Myotonic dystrophy treated with selenium and vitamin E","volume":"219","author":"Orndahl","year":"1986","journal-title":"Acta Medica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD004762.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2796.1994.tb01061.x","article-title":"Functional deterioration and selenium-vitamin E treatment in myotonic dystrophy. A placebo-controlled study","volume":"235","author":"Orndahl","year":"1994","journal-title":"Journal of internal medicine"},{"issue":"3","key":"10.1002\/14651858.CD004762.pub2-BIB0033|cit33","first-page":"591","article-title":"The treatment of myotonia with L-Dopa. Clinical and electromyographic study","volume":"78","author":"Pendefunda","year":"1974","journal-title":"Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi"},{"issue":"6","key":"10.1002\/14651858.CD004762.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.wnl.0000324257.35759.40","article-title":"Dehydroepiandrosterone for myotonic dystrophy type 1","volume":"71","author":"P\u00e9nisson-Besnier","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004762.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jnnp.43.3.268","article-title":"Successful treatment of paramyotonia congenita (Eulenburg): muscle stiffness and weakness prevented by tocainide","volume":"43","author":"Ricker","year":"1980","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00313157","article-title":"Improved therapy of myotonia with the lidocaine derivative tocainide","volume":"222(4)","author":"R\u00fcdel","year":"1980","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0037|cit37","first-page":"87","article-title":"Von Eulenberg's paramyotonia. A clinical study of restricted myotonia and episodic paralysis successfully controlled by chlorothiazide","volume":"89","author":"Samaha","year":"1964","journal-title":"Transactions of the American Neurological Association"},{"issue":"3","key":"10.1002\/14651858.CD004762.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/01.WNL.0000044405.29988.E1","article-title":"Creatine monohydrate in DM2\/PROMM: a double-blind placebo controlled clinical study. Proximal myotonic myopathy","volume":"60","author":"Schneider-Gold","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD004762.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000115546","article-title":"Carbamazepine versus diphenylhydantoin in the treatment of myotonia","volume":"22","author":"Sechi","year":"1983","journal-title":"European Neurology"},{"issue":"2","key":"10.1002\/14651858.CD004762.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/mus.880100209","article-title":"Paramyotonia congenita: successful treatment with tocainide. Clinical and electrophysiologic findings in seven patients","volume":"10","author":"Streib","year":"1987","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1002\/14651858.CD004762.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/WNL.51.2.586","article-title":"A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy","volume":"51","author":"Sugino","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004762.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mus.10527","article-title":"Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1","volume":"29","author":"Tarnopolsky","year":"2004","journal-title":"Muscle & Nerve"},{"issue":"12","key":"10.1002\/14651858.CD004762.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1210\/jcem.80.12.8530624","article-title":"Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy - a clinical research center study","volume":"80","author":"Vlachopapadopoulou","year":"1995","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"12","key":"10.1002\/14651858.CD004762.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00415-002-0923-x","article-title":"Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study","volume":"249","author":"Walter","year":"2002","journal-title":"Journal of Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004762.pub2-BIB0045|cit45","first-page":"A413","article-title":"Mexiletine: Effective antimyotonia treatment in myotonic dystrophy type I (DM1)","volume":"64","author":"Martens","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0046|cit46","first-page":"119","volume-title":"Statistical Methods in Medical Research","author":"Armitage","year":"1987"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/jmg.35.4.293","article-title":"Myotonia congenita in northern Finland: an epidemiological and genetic study","volume":"35","author":"Baumann","year":"1998","journal-title":"Journal of Medical Genetics"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0048|cit48","volume-title":"Paramyotonia Congenita (Eulenburg)","author":"Becker","year":"1970"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0049|cit49","volume-title":"Myotonia congenita and syndromes associated with myotonia. Clinical-genetic studies of the nondystrophic myotonias","author":"Becker","year":"1977"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/mus.20235","article-title":"Myocytes from congenital myotonic dystrophy display abnormal Na+ channel activities","volume":"31","author":"Bernareggi","year":"2005","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-642-67584-3_2","article-title":"Effects of adrenergic activators and inhibitors on the skeletal muscles","volume-title":"Handbook of experimental pharmacology: Adrenergic Activators and inhibitors, part II","volume":"54\/II","author":"Bowman","year":"1981"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0052|cit52","first-page":"165","volume-title":"Statistical Methods in Cancer Research: The analysis of case-control studies","volume":"I","author":"Breslow","year":"1980"},{"issue":"2","key":"10.1002\/14651858.CD004762.pub2-BIB0053|cit53","first-page":"385","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3'end of a transcript encoding a protein kinase family member","volume":"69","author":"Brook","year":"1992","journal-title":"Cell"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1651-2227.1992.tb12271.x","article-title":"Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine","volume":"81(5)","author":"Ceccarelli","year":"1992","journal-title":"Acta Paediatrica"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(02)00572-5","article-title":"Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing","volume":"10(1)","author":"Charlet-B","year":"2002","journal-title":"Molecular Cell"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01629597","volume":"45","author":"C\u00fcrschmann","year":"1912","journal-title":"Deutsche Zeitschrift f\u00fcr Nervenheilk\u00fcnde"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0057|cit57","first-page":"270","article-title":"Effects of tocainide on normal and myotonic mammalian skeletal muscle","volume":"29(2)","author":"Dengler","year":"1979","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"10.1002\/14651858.CD004762.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/brain\/124.2.352","article-title":"Propagation disturbance of motor unit action potentials during transient paresis in generalized myotonia: a high density surface EMG study","volume":"124","author":"Drost","year":"2001","journal-title":"Brain"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0059|cit59","volume-title":"Meyler's side effects of drugs","author":"Dukes","year":"2000"},{"issue":"11","key":"10.1002\/14651858.CD004762.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/archneur.1985.04060100049020","article-title":"Cardiac side effects of phenytoin and carbamazepine. A dose-related phenomenon?","volume":"42","author":"Durelli","year":"1985","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004762.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases - a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscular Disorders"},{"issue":"4983","key":"10.1002\/14651858.CD004762.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.2173143","article-title":"Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene","volume":"250","author":"Fontaine","year":"1990","journal-title":"Science"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0098-2997(97)00050-2","article-title":"Diseases caused by voltage-gated ion channels","volume":"18(6)","author":"Fontaine","year":"1997","journal-title":"Molecular Aspects of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004762.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0022-510X(74)90060-4","article-title":"The Schwartz-Jampel syndrome. Its clinical, physiological and histological expressions","volume":"22","author":"Fowler","year":"1974","journal-title":"Journal of the Neurological Sciences"},{"issue":"8","key":"10.1002\/14651858.CD004762.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/mus.880140811","article-title":"Altered Na+ channel activity and reduced Cl- conductance cause hyperexcitability in recessive generalized myotonia (Becker)","volume":"14","author":"Franke","year":"1991","journal-title":"Muscle & Nerve"},{"issue":"8","key":"10.1002\/14651858.CD004762.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00007611-199408000-00019","article-title":"Bone marrow granulomas, fever, pancytopenia, and lupus-like syndrome due to tocainide","volume":"87","author":"Gelfand","year":"1994","journal-title":"The southern medical journal"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/ng0493-305","article-title":"Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita)","volume":"3","author":"George","year":"1993","journal-title":"Nature Genetics"},{"issue":"8802","key":"10.1002\/14651858.CD004762.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/0140-6736(92)90729-M","article-title":"Unstable DNA sequence in myotonic dystrophy","volume":"339","author":"Harley","year":"1992","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0069|cit69","first-page":"47","article-title":"Other myotonic disorders and muscular dystrophies: the differential diagnosis of myotonic dystrophy","volume-title":"Myotonic dystrophy","author":"Harper","year":"2001"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oso\/9780198527824.003.0001","article-title":"Myotonic dystrophy: a multisystemic disorder","volume-title":"Myotonic Dystrophy","author":"Harper","year":"2004"},{"issue":"Pt 3","key":"10.1002\/14651858.CD004762.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/brain\/112.3.779","article-title":"Anticipation in myotonic dystrophy: fact or fiction?","volume":"112","author":"Howeler","year":"1989","journal-title":"Brain"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0072|cit72","article-title":"Chloride and sodium channel myotonias","volume-title":"Channelopathies of the nervous system","author":"Jurkat-Rott","year":"2001"},{"issue":"5071","key":"10.1002\/14651858.CD004762.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1379744","article-title":"The skeletal muscle chloride channel in dominant and recessive human myotonia","volume":"257","author":"Koch","year":"1992","journal-title":"Science"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.47.4.963","article-title":"Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect","volume":"47","author":"Koty","year":"1996","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0075|cit75","first-page":"49","article-title":"Value of mexiletine in the treatment of Thomsen-Becker myotonia","volume":"43(1)","author":"Leheup","year":"1986","journal-title":"Archives Fran\u00e7aises de P\u00e9diatrie"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.880100414","article-title":"Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH","volume":"10","author":"Lehmann-Horn","year":"1987","journal-title":"Muscle & Nerve"},{"issue":"7","key":"10.1002\/14651858.CD004762.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/mus.880100709","article-title":"Membrane defects in paramyotonia congenita (Eulenburg)","volume":"10","author":"Lehmann-Horn","year":"1987","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0078|cit78","first-page":"1303","article-title":"The periodic paralyses and paramyotonia congenita","volume-title":"Myology","author":"Lehmann-Horn","year":"1994"},{"issue":"10","key":"10.1002\/14651858.CD004762.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archneur.1992.00530340026009","article-title":"Myotonia fluctuans","volume":"49","author":"Lennox","year":"1992","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1113\/jphysiol.1993.sp019843","article-title":"Human sodium channel myotonia: slowed channel inactivation due to substitutions for a glycine within the III-IV linker","volume":"470","author":"Lerche","year":"1993","journal-title":"The Journal of Physiology"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0081|cit81","first-page":"533","article-title":"Myotonic disorders other than myotonic dystrophy","volume-title":"Handbook of Clinical Neurology","author":"Lipicky","year":"1979"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0082|cit82","volume-title":"Farmacotherapeutisch kompas","author":"Boer de","year":"2005"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000118206.49652.A3","article-title":"Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1","volume":"62(7)","author":"Logigian","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/mus.20339","article-title":"Quantitative analysis of the \"warm-up\" phenomenon in myotonic dystrophy type 1","volume":"32(1)","author":"Logigian","year":"2005","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","article-title":"Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy","volume":"10(1)","author":"Mankodi","year":"2002","journal-title":"Molecular Cell"},{"issue":"Suppl","key":"10.1002\/14651858.CD004762.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s100720070009","article-title":"Therapy in myotonic disorders and in muscle channelopathies","volume":"21","author":"Meola","year":"2000","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0035-3787(04)71007-3","article-title":"Treatment in myotonia and periodic paralysis","volume":"160(5 Pt 2)","author":"Meola","year":"2004","journal-title":"Revue neurologique"},{"issue":"2","key":"10.1002\/14651858.CD004762.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0960-8966(95)00036-4","article-title":"Proximal myotonic myopathy: mini review of a recently delineated clinical disorder","volume":"6","author":"Moxley","year":"1996","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ajh.2830170413","article-title":"Procainamide-induced agranulocytosis with reversible myeloid sensitivity","volume":"17","author":"Nelson","year":"1984","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/WNL.53.2.297","article-title":"Founder mutations and the high prevalence of myotonia congenita in northern Finland","volume":"53(2)","author":"Papponen","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1212\/WNL.50.4.1176","article-title":"Novel muscle chloride channel (CLCN1) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance","volume":"50","author":"Plassart-Schiess","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0092|cit92","first-page":"665","article-title":"Myotonia with muscular weakness corrected by exercise: the therapeutic effect of mexiletine","volume":"139(4)","author":"Pouget","year":"1983","journal-title":"Revue Neurologique"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.44.8.1500","article-title":"Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita and hyperkalemic periodic paralysis","volume":"44(8)","author":"Pt\u00e1cek","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004762.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0002-9343(98)00123-5","article-title":"The familial periodic paralyses and nondystrophic myotonias","volume":"105","author":"Pt\u00e1cek","year":"1998","journal-title":"The American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00312881","article-title":"Transient muscular weakness in severe recessive myotonia congenita. Improvement of isometric muscle force by drugs relieving myotonic stiffness","volume":"218","author":"Ricker","year":"1978","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004762.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/archneur.1990.00530030034012","article-title":"Myotonia fluctuans","volume":"47","author":"Ricker","year":"1990","journal-title":"Archives of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD004762.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archneur.1994.00540230033009","article-title":"Myotonia fluctuans. A third type of muscle sodium channel disease","volume":"51","author":"Ricker","year":"1994","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD004762.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s004150050359","article-title":"Myotonic dystrophy and proximal myotonic myopathy","volume":"246","author":"Ricker","year":"1999","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD004762.pub2-BIB0099|cit99","first-page":"413","article-title":"Electrophysiological evaluation of congenital myotonia","volume":"25","author":"Rossi","year":"1985","journal-title":"Electromyography and Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0100|cit100","first-page":"1291","article-title":"Altered excitability of the muscle cell membrane. The non-dystrophic myotonias","volume-title":"Myology","author":"R\u00fcdel","year":"1994"},{"issue":"2","key":"10.1002\/14651858.CD004762.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0960-8966(96)00418-X","article-title":"Paramyotonia, potassium-aggravated myotonias and periodic paralyses. 37th ENMC International Workshop, Naarden, The Netherlands, 8-10 December 1995","volume":"7","author":"R\u00fcdel","year":"1997","journal-title":"Neuromuscular Disorders"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0102|cit102","first-page":"127","article-title":"Muscle ion channelopathies","volume":"3","author":"R\u00fcdel","year":"1999","journal-title":"Acta Myologica"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"S971","DOI":"10.1007\/s100720070012","article-title":"Quantitative myotonia assessment: an experimental protocol","volume":"21(5 Suppl)","author":"Sansone","year":"2000","journal-title":"Neurological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD004762.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ajh.2830270413","article-title":"Procainamide-associated pancytopenia","volume":"27","author":"Shields","year":"1988","journal-title":"American Journal of Hematology"},{"issue":"3","key":"10.1002\/14651858.CD004762.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.1987.00370030196040","article-title":"Tocainide-induced reversible agranulocytosis and anemia","volume":"147","author":"Soff","year":"1987","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF01649715","volume":"39","author":"Steinert","year":"1910","journal-title":"Deutsche Zeitschrift f\u00fcr Nervenheilk\u00fcnde"},{"issue":"5","key":"10.1002\/14651858.CD004762.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ana.410190515","article-title":"Successful treatment with tocainide of recessive generalized congenital myotonia","volume":"19","author":"Streib","year":"1986","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/BF02164912","article-title":"Tonische krampfe in willkurlich beweglichen muskeln in folge von erebter psychischer disposition (Ataxia muscularis?)","volume":"6","author":"Thomsen","year":"1876","journal-title":"Archiv f\u00fcr Psychiatrie und Nervenkrankheiten"},{"issue":"2","key":"10.1002\/14651858.CD004762.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0002-8703(69)90024-6","article-title":"Agranulocytosis following procainamide administration","volume":"78","author":"Wang","year":"1969","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD004762.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurpsyc.1936.02260080154011","article-title":"Quinine: an effective form of treatment of myotonia","volume":"36","author":"Wolf","year":"1936","journal-title":"Archives of Neurology and Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004762.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004762.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T10:37:06Z","timestamp":1706870226000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004762.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,1,25]]},"references-count":110,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004762.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,25]]}}}